Latest Insider Transactions at Centene Corp (CNC)
This section provides a real-time view of insider transactions for Centene Corp (CNC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CENTENE CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CENTENE CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 13
2024
|
Lori Jean Robinson Director |
SELL
Open market or private sale
|
Direct |
10,000
-46.61%
|
$770,000
$77.41 P/Share
|
|
Feb 13
2024
|
Lori Jean Robinson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+31.79%
|
$540,000
$54.65 P/Share
|
|
Feb 07
2024
|
Kenneth J Fasola President |
SELL
Open market or private sale
|
Direct |
12,000
-2.45%
|
$900,000
$75.21 P/Share
|
|
Feb 06
2024
|
Sarah London Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,739
-3.0%
|
$1,238,686
$74.07 P/Share
|
|
Feb 06
2024
|
Sarah London Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,920
+1.4%
|
-
|
|
Feb 06
2024
|
Christopher Koster Secretary & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
13,449
-7.59%
|
$995,226
$74.07 P/Share
|
|
Feb 06
2024
|
Christopher Koster Secretary & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
6,336
+3.45%
|
-
|
|
Feb 06
2024
|
Andrew Lynn Asher Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,955
-3.65%
|
$1,106,670
$74.07 P/Share
|
|
Feb 06
2024
|
Andrew Lynn Asher Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,920
+1.9%
|
-
|
|
Feb 06
2024
|
Kenneth A Burdick Director |
SELL
Payment of exercise price or tax liability
|
Direct |
33,066
-8.46%
|
$2,446,884
$74.07 P/Share
|
|
Feb 06
2024
|
Kenneth A Burdick Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,563
+4.53%
|
-
|
|
Jan 19
2024
|
Kenneth J Fasola President |
SELL
Payment of exercise price or tax liability
|
Direct |
7,001
-2.75%
|
$532,076
$76.6 P/Share
|
|
Jan 04
2024
|
Kenneth J Fasola President |
SELL
Payment of exercise price or tax liability
|
Direct |
14,373
-5.35%
|
$1,106,721
$77.21 P/Share
|
|
Dec 31
2023
|
Kenneth A Burdick Director |
BUY
Grant, award, or other acquisition
|
Direct |
485
+0.13%
|
-
|
|
Dec 31
2023
|
Frederick H Eppinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
433
+0.13%
|
-
|
|
Dec 31
2023
|
Wayne S De Veydt Director |
BUY
Grant, award, or other acquisition
|
Direct |
537
+5.1%
|
-
|
|
Dec 31
2023
|
Christopher J Coughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
502
+2.21%
|
-
|
|
Dec 31
2023
|
Theodore R. Samuels Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
433
+4.29%
|
-
|
|
Dec 15
2023
|
Sarah London Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,119
-0.92%
|
$383,925
$75.51 P/Share
|
|
Dec 15
2023
|
Christopher Koster Secretary & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,889
-2.78%
|
$366,675
$75.51 P/Share
|
|
Dec 15
2023
|
Andrew Lynn Asher Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,548
-1.12%
|
$341,100
$75.51 P/Share
|
|
Dec 15
2023
|
David P Thomas CEO, Markets and Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
2,433
-1.8%
|
$182,475
$75.51 P/Share
|
|
Sep 30
2023
|
Theodore R. Samuels Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
469
+4.83%
|
-
|
|
Sep 30
2023
|
Frederick H Eppinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
469
+0.14%
|
-
|
|
Sep 30
2023
|
Wayne S De Veydt Director |
BUY
Grant, award, or other acquisition
|
Direct |
582
+5.79%
|
-
|
|
Sep 30
2023
|
Christopher J Coughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
544
+2.45%
|
-
|
|
Sep 30
2023
|
Kenneth A Burdick Director |
BUY
Grant, award, or other acquisition
|
Direct |
526
+0.14%
|
-
|
|
Sep 14
2023
|
Sarah London Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,805
-0.68%
|
$258,740
$68.34 P/Share
|
|
Jun 30
2023
|
Frederick H Eppinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
468
+0.14%
|
-
|
|
Jun 30
2023
|
Theodore R. Samuels Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
468
+5.07%
|
-
|
|
Jun 30
2023
|
Wayne S De Veydt Director |
BUY
Grant, award, or other acquisition
|
Direct |
581
+6.14%
|
-
|
|
Jun 30
2023
|
Kenneth A Burdick Director |
BUY
Grant, award, or other acquisition
|
Direct |
524
+0.14%
|
-
|
|
Jun 30
2023
|
Christopher J Coughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
543
+2.5%
|
-
|
|
Jun 23
2023
|
Christopher Koster Secretary & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,994
-1.12%
|
$131,604
$66.8 P/Share
|
|
Jun 23
2023
|
Sarah London Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,994
-0.36%
|
$131,604
$66.8 P/Share
|
|
May 10
2023
|
Christopher J Coughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,947
+12.51%
|
-
|
|
May 10
2023
|
H James Dallas Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,947
+7.31%
|
-
|
|
May 10
2023
|
Wayne S De Veydt Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,947
+26.2%
|
-
|
|
May 10
2023
|
Frederick H Eppinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,157
+1.47%
|
-
|
|
May 10
2023
|
Monte E Ford Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,947
+40.45%
|
-
|
|
May 10
2023
|
Lori Jean Robinson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,947
+20.46%
|
-
|
|
May 10
2023
|
Theodore R. Samuels Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,947
+26.2%
|
-
|
|
May 10
2023
|
Jessica L. Blume Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,947
+11.87%
|
-
|
|
May 10
2023
|
Kenneth A Burdick Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,947
+0.79%
|
-
|
|
May 07
2023
|
Andrew Lynn Asher Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,559
-1.59%
|
$446,012
$68.39 P/Share
|
|
Apr 27
2023
|
Lori Jean Robinson Director |
SELL
Open market or private sale
|
Direct |
1,400
-14.13%
|
$92,400
$66.59 P/Share
|
|
Apr 26
2023
|
Andrew Lynn Asher Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,638
-1.11%
|
$320,022
$69.29 P/Share
|
|
Apr 01
2023
|
Katie Casso Corporate Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
925
-1.76%
|
$58,275
$63.21 P/Share
|
|
Mar 31
2023
|
Frederick H Eppinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
440
+0.13%
|
-
|
|
Mar 31
2023
|
Christopher J Coughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
510
+2.81%
|
-
|